These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 21344555)

  • 1. A regioselective biocatalyst for alkane activation under mild conditions.
    Bordeaux M; Galarneau A; Fajula F; Drone J
    Angew Chem Int Ed Engl; 2011 Feb; 50(9):2075-9. PubMed ID: 21344555
    [No Abstract]   [Full Text] [Related]  

  • 2. Regio- and enantioselective alkane hydroxylation with engineered cytochromes P450 BM-3.
    Peters MW; Meinhold P; Glieder A; Arnold FH
    J Am Chem Soc; 2003 Nov; 125(44):13442-50. PubMed ID: 14583039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regioselective ω-hydroxylation of medium-chain n-alkanes and primary alcohols by CYP153 enzymes from Mycobacterium marinum and Polaromonas sp. strain JS666.
    Scheps D; Malca SH; Hoffmann H; Nestl BM; Hauer B
    Org Biomol Chem; 2011 Oct; 9(19):6727-33. PubMed ID: 21837346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of perfluorocarboxylic acids to trick cytochrome P450BM3 into initiating the hydroxylation of gaseous alkanes.
    Kawakami N; Shoji O; Watanabe Y
    Angew Chem Int Ed Engl; 2011 May; 50(23):5315-8. PubMed ID: 21506212
    [No Abstract]   [Full Text] [Related]  

  • 5. Alkane hydroxylation by peroxy acids: a comparison with the cytochrome P450 hydroxylation.
    Groenhof AR; Ehlers AW; Lammertsma K
    J Phys Chem A; 2008 Dec; 112(50):12855-61. PubMed ID: 18956858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Achieving regio- and enantioselectivity of P450-catalyzed oxidative CH activation of small functionalized molecules by structure-guided directed evolution.
    Agudo R; Roiban GD; Reetz MT
    Chembiochem; 2012 Jul; 13(10):1465-73. PubMed ID: 22711296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanding the toolbox of organic chemists: directed evolution of P450 monooxygenases as catalysts in regio- and stereoselective oxidative hydroxylation.
    Roiban GD; Reetz MT
    Chem Commun (Camb); 2015 Feb; 51(12):2208-24. PubMed ID: 25483552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase.
    Roitel O; Scrutton NS; Munro AW
    Biochemistry; 2003 Sep; 42(36):10809-21. PubMed ID: 12962506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel P450-based biocatalyst for the selective production of chiral 2-alkanols.
    von Bühler CJ; Urlacher VB
    Chem Commun (Camb); 2014 Apr; 50(31):4089-91. PubMed ID: 24618874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Model of the active center of cytochrome P-450. Alkane oxidation catalyzed by iron(III) porphyrin in microheterogeneous media].
    Sorokin AB; Khenkin AM; Marakushev SA; Shilov AE; Shteĭnman AA
    Dokl Akad Nauk SSSR; 1984; 279(4):939-41. PubMed ID: 6525960
    [No Abstract]   [Full Text] [Related]  

  • 11. Oxygen activation by cytochrome P450BM-3: effects of mutating an active site acidic residue.
    Yeom H; Sligar SG
    Arch Biochem Biophys; 1997 Jan; 337(2):209-16. PubMed ID: 9016815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The valence bond way: reactivity patterns of cytochrome P450 enzymes and synthetic analogs.
    Shaik S; Lai W; Chen H; Wang Y
    Acc Chem Res; 2010 Aug; 43(8):1154-65. PubMed ID: 20527755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A predictive pattern of computed barriers for C-h hydroxylation by compound I of cytochrome p450.
    de Visser SP; Kumar D; Cohen S; Shacham R; Shaik S
    J Am Chem Soc; 2004 Jul; 126(27):8362-3. PubMed ID: 15237977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Factors determining the selectivity of cytochrome P-450-catalyzed alkane oxidation].
    Karasevich EI; Khenkin AM
    Biokhimiia; 1986 Sep; 51(9):1454-8. PubMed ID: 3768443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alkane hydroxylation by a nonheme iron catalyst that challenges the heme paradigm for oxygenase action.
    Company A; Gómez L; Güell M; Ribas X; Luis JM; Que L; Costas M
    J Am Chem Soc; 2007 Dec; 129(51):15766-7. PubMed ID: 18052284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-state reactivity mechanisms of hydroxylation and epoxidation by cytochrome P-450 revealed by theory.
    Shaik S; de Visser SP; Ogliaro F; Schwarz H; Schröder D
    Curr Opin Chem Biol; 2002 Oct; 6(5):556-67. PubMed ID: 12413538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of a minimal enriched P450 BM3 mutant library for hydroxylation of cyclic and acyclic alkanes.
    Weber E; Seifert A; Antonovici M; Geinitz C; Pleiss J; Urlacher VB
    Chem Commun (Camb); 2011 Jan; 47(3):944-6. PubMed ID: 21079837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation and binding of carbanions by cytochrome P-450 of liver microsomes.
    Ullrich V; Schnabel KH
    Drug Metab Dispos; 1973; 1(1):176-83. PubMed ID: 4149380
    [No Abstract]   [Full Text] [Related]  

  • 19. Mechanistic studies with purified components of the liver microsomal hydroxylation system: spectral intermediates in reaction of cytochrome P-450 with peroxy compounds.
    Coon MJ; Blake RC; Oprian DD; Ballou DP
    Acta Biol Med Ger; 1979; 38(2-3):449-58. PubMed ID: 42250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytochrome P-450 and alkane hydroxylase activity in Candida guilliermondii.
    Schunck WH; Riege P; Blasig R; Honeck H; Müller HG
    Acta Biol Med Ger; 1978; 37(1):K3-K7. PubMed ID: 30246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.